tiprankstipranks
Alibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
PremiumThe FlyAlibaba upgraded, Rivian downgraded: Wall Street’s top analyst calls
1M ago
BioMarin upgraded to Outperform from Perform at Oppenheimer
Premium
The Fly
BioMarin upgraded to Outperform from Perform at Oppenheimer
1M ago
Oppenheimer upgrades BioMarin with stage set for increasing interest
Premium
The Fly
Oppenheimer upgrades BioMarin with stage set for increasing interest
1M ago
BioMarin Pharmaceutical: Strong Growth Prospects with Strategic Initiatives Justifying Buy Rating
PremiumRatingsBioMarin Pharmaceutical: Strong Growth Prospects with Strategic Initiatives Justifying Buy Rating
1M ago
BioMarin price target raised to $80 from $78 at Scotiabank
Premium
The Fly
BioMarin price target raised to $80 from $78 at Scotiabank
1M ago
BioMarin price target raised to $113 from $109 at UBS
Premium
The Fly
BioMarin price target raised to $113 from $109 at UBS
1M ago
BioMarin price target raised to $126 from $122 at Piper Sandler
PremiumThe FlyBioMarin price target raised to $126 from $122 at Piper Sandler
1M ago
BioMarin price target raised to $82 from $81 at Citi
Premium
The Fly
BioMarin price target raised to $82 from $81 at Citi
1M ago
BioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
Premium
Ratings
BioMarin Pharmaceutical: Hold Rating Amid Strong Performance and Decelerating Growth Prospects
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100